Business Description
Orion Nutraceuticals Inc
NAICS : 325412
SIC : 3741
ISIN : CA68629J2056
Share Class Description:
FRA:86OA: Ordinary SharesCompare
Compare
Traded in other countries / regions
ORI.Canada86OA.Germany IPO Date
2019-07-11Description
Orion Nutraceuticals Inc focuses on re-purposing a United States Food and Drug Administration approved drug to target asthma and chronic obstructive pulmonary disease (COPD).
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.57 | |||||
Equity-to-Asset | -1.15 | |||||
Debt-to-Equity | -0.19 | |||||
Debt-to-EBITDA | -0.43 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 5/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 67.2 | |||||
3-Year EPS without NRI Growth Rate | 67.1 | |||||
3-Year FCF Growth Rate | 56.9 | |||||
3-Year Book Growth Rate | 7.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.47 | |||||
Quick Ratio | 0.47 | |||||
Cash Ratio | 0.47 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -63.4 | |||||
Shareholder Yield % | -0.32 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | Neg. Equity | |||||
ROA % | 120.71 | |||||
ROIC % | -249.02 | |||||
3-Year ROIIC % | 571.74 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 200 | |||||
PE Ratio without NRI | 40 | |||||
EV-to-EBIT | -44.6 | |||||
EV-to-EBITDA | -44.6 | |||||
EV-to-FCF | -539.48 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.58 | |||||
Earnings Yield (Greenblatt) % | -2.24 | |||||
FCF Yield % | -0.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Orion Nutraceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | 0.003 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR (€) | 0 | ||
20-Day SMA (€) | 0.348 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (€) | 0.348 - 0.348 | ||
Shares Outstanding (Mil) | 29.31 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Orion Nutraceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Orion Nutraceuticals Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Orion Nutraceuticals Inc Frequently Asked Questions
What is Orion Nutraceuticals Inc(FRA:86OA)'s stock price today?
The current price of FRA:86OA is €0.35. The 52 week high of FRA:86OA is €0.35 and 52 week low is €0.35.
When is next earnings date of Orion Nutraceuticals Inc(FRA:86OA)?
The next earnings date of Orion Nutraceuticals Inc(FRA:86OA) is .
Does Orion Nutraceuticals Inc(FRA:86OA) pay dividends? If so, how much?
Orion Nutraceuticals Inc(FRA:86OA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |